Locations:

Research

February 20, 2017/Cancer/Research

Diagnostic and Treatment Guidelines Established for Myeloproliferative Neoplasms

NCCN guidelines include ruxolitinib use

February 14, 2017/Cancer/Research

Radiation Oncology Gets a Dose of Precision Medicine

New algorithm predicts response to radiation based on genomics

February 6, 2017/Cancer/Research

Promise of PARP Inhibitors for BRCA1/BRCA2 Cancers

Clinical trials testing olaparib in breast cancer

January 20, 2017/Cancer/Research

February Cancer Clinical Trials

Learn about featured cancer clinical trials currently enrolling, or search our cancer clinical trials database for all open and accruing studies

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

January 18, 2017/Cancer/Research

ASH 2016 Top 10 Abstracts

Hard hitters that caught our attention

January 16, 2017/Cancer/Research

Researchers Discover How Glioblastoma Stem Cells Evade the Immune System

Finding has potential to improve treatment

December 9, 2016/Cancer/Research

Scalp Cooling Reduces Chemotherapy-Induced Hair Loss

Breast cancer trial proves benefits of scalp cooling

December 7, 2016/Cancer/Research

Contradictory Conclusions Reached in Extended Adjuvant Endocrine Therapy for Breast Cancer

Prolonged endocrine therapy for postmenopausal disease did not confer benefits

December 6, 2016/Cancer/Research

Pacritinib Outperforms Best Available Therapy for Myelofibrosis

Investigators working with FDA on safety signal

December 5, 2016/Cancer/Research

Vadastuximab for AML: Investigator Predicts Changes to Standard Therapy in Near Future

Drug targets CD33 to produce high remission rates

BackPage 31 of 42Next